Navigation Links
PDL BioPharma to Announce Second Quarter 2009 Financial Results and Hold Conference Call July 30, 2009
Date:7/22/2009

INCLINE VILLAGE, Nev., July 22 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that the company will hold a conference call and webcast on Thursday, July 30 at 4:30 p.m. Eastern Time to discuss its financial results for the second quarter of 2009 and provide a business update. The call and webcast will follow the release of the second quarter ended June 30, 2009 financial results after market close.

Conference Call Details

To access the live conference call via phone, please dial (866) 510-0707 from the United States and Canada or (617) 597-5376 internationally. The conference ID is 27369299. Please dial in approximately ten minutes prior to the start of the call. A telephone replay will be available beginning approximately one hour after the call through August 6, and may be accessed by dialing (888) 286-8010 from the United States and Canada or (617) 801-6888 internationally. The replay passcode is 58547023.

To access the live and subsequently archived webcast of the conference call, go to the company's Web site athttp://www.pdl.com and click "Investors." Please connect to the web site at least 15 minutes prior to the call to allow for any software download that may be necessary.

About PDL BioPharma, Inc.

PDL BioPharma pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. PDL is focused on maximizing the value of its antibody humanization patents and related assets. The company receives royalties on sales of a number of humanized antibody products marketed today and also may receive royalty payments on additional humanized antibody produc
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. DOR BioPharma Appoints Christopher P. Schnittker, CPA, as Vice President of Administration and Controller
2. AlphaRx and Gaia BioPharma Report Positive Efficacy Results in a Pre-Clinical Trial of GAI-122 Injectable Nano-emulsion for Post-operative Delirium
3. Helix Biopharma Corp. Begins Trading on the OTCQX International Market Listing as HXBPF
4. Sinobiopharma Receives Trademark Approval and Authentication From Chinese Government For Its Tai Drug Series
5. Keryx Biopharmaceuticals Inc. Regains Compliance With NASDAQ Listing Requirements
6. AlphaRx and Gaia BioPharma Provide GAI-122 Development Update
7. PDL BioPharma Announces Record Date for October 1 Dividend Payment
8. Keryx Biopharmaceuticals, Inc. Receives Extension for Nasdaq Listing Compliance
9. SAFE-BioPharma Webinar Featuring ARX's Digital Signatures Combined with Microsoft SharePoint for Bio-Pharma industry
10. Prix Galien USA Now Accepting Nominations for Premiere Biopharmaceutical Industry Award
11. The Sage Group Widens Strategic Role to Assist HemispherX Biopharma in Pandemic Influenza Initiatives as Pacific Rim/Japan Treatment/Prevention Programs Accelerate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... LiveSchool ” was featured on NewsWatch as part of ... latest and coolest applications on the market for iOS, ... and technology expert, conducted the app review and shared ... students with good behavior. , Positive re-enforcement is more ... And the good people at LiveSchool have taken note ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 The opportunity for ... full life are the motivating forces behind The Fairy Godmother ... psychologist and author Amy L. Stark. , The inspiration for ... girl next door comes from Stark’s desire to be a ... been a fairy godmother to my neighbors’ children since they ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 The U.S. ... baby boomers join the ranks of senior citizens (1) ... on an already over-burdened healthcare system. Additionally, as older ... to replace them. Per the U.S. Census Bureau, the ... to increase 75% by 2050 while those 25 to ...
(Date:5/4/2015)... OK and Seattle, WA (PRWEB) May 04, 2015 ... the formation of a collaboration to facilitate development of ... of ophthalmic disorders that lead to blindness, including Diabetic ... the MiDROPS™ formulation platform developed by EyeCRO, which can ... eye via a topical eyedrop. , Under the ...
(Date:5/4/2015)... 04, 2015 New findings released today ... Association (ABTA) show that people diagnosed with a brain ... options, including clinical trials, at the time of diagnosis, ... difficult decisions about their course of treatment. The release ... first nationwide brain tumor volunteer network, the ABTA CommYOUnity™, ...
Breaking Medicine News(10 mins):Health News:An Application for Teachers to Reward Students with Good Behavior Was Featured on NewsWatch Television 2Health News:Introducing New Children’s Book The Fairy Godmother Next Door 2Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 2Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 3Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 4Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 3Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3
... Highlights, - Revenue for the first quarter was $480.6 million, up 7.6% from ... ... ("FOI") grew 7.2% for the twelve, months ended March 31, 2008 over ... was $38.6 million, or $0.38,per outstanding common share, a 19% increase over the ...
... project as innovative in terms of energy efficiency and ... awarded nearly $27 million in funding for a new ... (USC). USC was one of 12 California institutions considered ... million to build stem cell research facilities throughout California. ...
... May 8, 2008 at 2:00 pm ET, MISSION ... ENSG ), the parent company of the Ensign(TM) ... today reported results for the first quarter of fiscal ... ) Highlights of the First Quarter Include:, ...
... 7 Conseco, Inc. (NYSE: CNO ),today reported ... set a new quarterly sales record with an increase ... Prieur said. "This performance included,an 11% increase at Bankers ... increase in total sales including new product offerings) of ...
... , Ottawa (May 7, 2008) The Honourable ... the Canadian Institutes of Health Research (CIHR) for 764 ... Minister Clement was joined by Dr. Patrick McGrath, a ... neonatologist and CIHR-funded researcher from the University of Alberta, ...
... 7 Dr. Hugo Stephenson, founder and ... drug safety, today,presented new insight about the ... the U.S. Food and Drug Administration (FDA). ... (rosuvastatin),Lipitor (atorvastatin), and Zocor (simvastatin) all warn ...
Cached Medicine News:Health News:Brookdale Announces First Quarter 2008 Results 2Health News:Brookdale Announces First Quarter 2008 Results 3Health News:Brookdale Announces First Quarter 2008 Results 4Health News:Brookdale Announces First Quarter 2008 Results 5Health News:Brookdale Announces First Quarter 2008 Results 6Health News:Brookdale Announces First Quarter 2008 Results 7Health News:Brookdale Announces First Quarter 2008 Results 8Health News:Brookdale Announces First Quarter 2008 Results 9Health News:Brookdale Announces First Quarter 2008 Results 10Health News:Brookdale Announces First Quarter 2008 Results 11Health News:Brookdale Announces First Quarter 2008 Results 12Health News:Brookdale Announces First Quarter 2008 Results 13Health News:Brookdale Announces First Quarter 2008 Results 14Health News:Brookdale Announces First Quarter 2008 Results 15Health News:Brookdale Announces First Quarter 2008 Results 16Health News:Brookdale Announces First Quarter 2008 Results 17Health News:Brookdale Announces First Quarter 2008 Results 18Health News:Brookdale Announces First Quarter 2008 Results 19Health News:Brookdale Announces First Quarter 2008 Results 20Health News:Brookdale Announces First Quarter 2008 Results 21Health News:Brookdale Announces First Quarter 2008 Results 22Health News:USC receives nearly $27 million in funding for new stem cell research facility 2Health News:The Ensign Group, Inc. Reports First Quarter 2008 Earnings 2Health News:The Ensign Group, Inc. Reports First Quarter 2008 Earnings 3Health News:The Ensign Group, Inc. Reports First Quarter 2008 Earnings 4Health News:The Ensign Group, Inc. Reports First Quarter 2008 Earnings 5Health News:The Ensign Group, Inc. Reports First Quarter 2008 Earnings 6Health News:The Ensign Group, Inc. Reports First Quarter 2008 Earnings 7Health News:The Ensign Group, Inc. Reports First Quarter 2008 Earnings 8Health News:The Ensign Group, Inc. Reports First Quarter 2008 Earnings 9Health News:The Ensign Group, Inc. Reports First Quarter 2008 Earnings 10Health News:Conseco Reports First Quarter Results 2Health News:Conseco Reports First Quarter Results 3Health News:Conseco Reports First Quarter Results 4Health News:Conseco Reports First Quarter Results 5
(Date:5/4/2015)... N.J. , May 4, 2015 Thirty-six ... percent seek help. During May – National Hearing Month ... loss could be missing out on the sounds of ... the trees. To ensure that you won,t ... that color our world, Oticon, Inc. offers practical advice: ...
(Date:5/4/2015)... WORCESTER, Mass. and TORONTO ... ( www.generex.com ) (OTCQB:GNBT) today announced that it intends ... securities it receives upon completion of a definitive licensing ... to Smoofi, Inc. ( www.smoofi.com ) (OTCQB:SMFI). ... a non-binding letter of intent in respect of the ...
(Date:5/4/2015)... , May 4, 2015 RadiologyAuction will have their ... video and product demonstrations at the end of the ... such as Kodak and Fuji Cr,s, Agfa and Sony, ... the first event. Various imaging equipment will be available ... After years of buying and selling imaging ...
Breaking Medicine Technology:It's Better Hearing Month 2Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 2Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 3Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 4Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 5RadiologyAuction Announces Event Starting On May 5th 2
... 16, Uroplasty, Inc. (Nasdaq: UPI ), ... innovative proprietary products to treat voiding dysfunctions, announced today ... Jiwani, Uroplasty,s Vice President and CFO, will present the ... Hunter Securities Inaugural Healthcare Conference at 3:30  PM PDT ...
... a crippling disease worldwide, with an estimated eight million sufferers ... a suit of rusty armour," with unrelenting, razor-like pain. ... reverse the degenerative condition. However a discovery made ... hold the key to not only halting the degenerative process, ...
Cached Medicine Technology:Uroplasty to Present at Global Hunter Securities Inaugural Healthcare Conference 2New Hope For Joint Pain Sufferers 2New Hope For Joint Pain Sufferers 3
Pocket-sized instrument, powered by two AA-sized alkaline batteries. Built-in throat illuminator, rectangular viewing lens for instrumentation under magnification....
The Pneumatic Consulting Otoscope provides two viewing lenses for dual observation of the tympanic membrane. Sealed system for pneumnatic otoscopy and rotatable head for left- and right-sided viewin...
Provides 30% more magnification and twice the field of view. Adjustable focus, with insufflator bulb....
... to laser treatment of AMD patients ... compares to the Opal Photoactivator from,Lumenis. ... (verteporfin for injection) therapy, the Opal ... any other laserfeatures,that ensure the highest ...
Medicine Products: